<< Back To Search

A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
Doctors are testing a new treatment called targeted therapy for a type of cancer called Smoldering Multiple Myeloma. The treatment involves using three drugs: Lenalidomide, Citarinostat (CC-96241), and PVX-410. The study is being done to see if this treatment can help people with Smoldering Multiple Myeloma.
*Third Opinion AI Generated Synopsis

Trial Summary
This research study is studying a targeted therapy as a possible treatment for Smoldering Multiple Myeloma. The following intervention will be involved in this study: Lenalidomide Citarinostat (CC-96241) PVX-410

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?